CEG, OKLO, and SMR Get Set to Power the AI Boom via Nuclear Energy

The nuclear energy sector is experiencing a resurgence driven by the energy demands of AI, with Constellation Energy (CEG), Oklo (OKLO), and NuScale Power (SMR) leading the charge. CEG recently secured a 20-year, 1.1 gigawatt power purchase agreement with Meta, highlighting its capacity to serve tech giants, while Oklo, backed by Sam Altman, focuses on small modular reactors (SMRs) and has seen its stock surge. NuScale Power, with its approved SMR design, is advancing a 2-gigawatt agreement to supply data centers, positioning these companies at the forefront of a transformative energy revolution despite facing challenges such as valuation concerns, cash burn, and operational risks.

Analysis

The nuclear energy sector is experiencing a notable resurgence, primarily driven by the substantial energy requirements of the expanding artificial intelligence industry, prompting major technology companies like Meta, Microsoft, and Alphabet to seek reliable, clean power sources. Constellation Energy (CEG) affirmed its leading position in the U.S. nuclear market by securing a 20-year, 1.1-gigawatt power purchase agreement with Meta for its Clinton Clean Energy Center, a deal commencing in 2027 that also boosts the plant's output by 30 megawatts and averts its potential closure. This agreement, complementing an existing one with Microsoft for the Three Mile Island restart, highlights CEG's extensive capacity with 94 reactors and its strategic shift towards grid-connected projects following regulatory hurdles. Despite a 30% year-to-date stock rally, analysts maintain a Moderate Buy consensus on CEG with an average price target of $319.45, implying approximately 10% upside, though its current valuation is noted as a consideration. Oklo (OKLO), a newer entrant backed by OpenAI's Sam Altman and focusing on small modular reactors (SMRs), has seen its stock increase by 440% over the past year, buoyed by significant agreements such as a 12-gigawatt deal with Switch and a memorandum with Korea Hydro & Nuclear Power. Oklo, which is pre-revenue and pursuing a "power-as-a-service" model, faces considerable R&D and scaling cost risks, but benefits from easing nuclear regulations; analysts assign it a Moderate Buy rating with an average target of $54.40, suggesting about 15% upside, while noting its significant cash burn. NuScale Power (SMR) holds a first-mover advantage with the first U.S. Nuclear Regulatory Commission approval for its SMR design and is advancing a 2-gigawatt agreement with Standard Power. NuScale reported an 857% year-over-year revenue increase in Q1, though it continues to post losses due to investments in its supply chain. Its more established light-water reactor technology is considered less experimental, but the company confronts supply chain constraints and project coordination challenges. Analysts rate SMR a Moderate Buy; however, its average price target of $27.42 indicates a potential 12% downside. With AI data centers projected to consume 9% of U.S. electricity by 2030 and nuclear capacity expected to quadruple by 2050, these companies are strategically positioned, yet each must navigate distinct challenges related to valuation, cash flow, and operational execution.

Key Decisions for Investors

• Investors should consider the nuclear energy sector's growth trajectory, propelled by AI's escalating power demands, while carefully distinguishing the investment profiles of established operators like Constellation Energy against development-stage SMR firms such as Oklo and NuScale Power.
• For Constellation Energy, evaluate whether its significant contract wins and market leadership adequately support its current stock valuation, which has seen substantial appreciation; for Oklo, closely monitor its progress towards commercial operations, successful technology scaling, and management of its pre-revenue cash burn.
• Regarding NuScale Power, critically assess its ability to execute on large-scale agreements like the Standard Power deal and mitigate supply chain risks, particularly in light of analyst consensus price targets suggesting potential downside despite its regulatory approvals and innovative SMR technology.